EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts

Uk Jeong, Ji-Hun An, Na-Hyun Park, Jin-Woo Min, Jun-Chae Lee, Yu-Ran Heo, Jae-Ho Lee

Current Issues in Molecular Biology · 16.11.2026 · 48 (11) · 1230

DOI: 10.3390/cimb48111230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 16.11.2026. Verfasst von Uk Jeong und 6 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CCND2 has context-dependent roles in cancer, but its prognostic relevance in the major histological subtypes of non-small cell lung cancer remains uncertain. We evaluated CCND2 separately in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) using The Cancer Genome Atlas (TCGA)data from OncoLnc and the Genomic Data Commons, together with three independent Gene Expression Omnibus (GEO) cohorts. Continuous-expression overall survival (OS) models were prespecified as the principal survival analyses. In matched tumor–normal pairs, CCND2 expression was lower in LUAD tumors (p < 0.001), with a nonsignificant difference in LUSC (p = 0.054). In TCGA-LUAD, higher CCND2 expression was associated with a lower mortality hazard after clinical adjustment (HR per SD = 0.839, 95% CI 0.722–0.975, p = 0.022; 0.841 without the pack-years-recorded indicator), with similar estimates in detailed-stage, EGFR-adjusted, and purity-adjusted models. The LUSC association was nonsignificant (HR = 0.888, 95% CI 0.776–1.017, p = 0.085), and a formal histology interaction test was nonsignificant (p = 0.235). Adding CCND2 to clinical models yielded only a small, uncertain gain in the C-index. External associations were heterogeneous and partly probe-dependent, and pooled estimates were nonsignificant in both histologies. Gene correlations were small, and pathway enrichments described bulk-tissue association patterns. CCND2 is an exploratory prognostic candidate in LUAD that requires further validation before clinical application.

Zitieren

APA

Jeong, U., An, J., Park, N., Min, J., Lee, J., Heo, Y., & Lee, J. (2026). CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts. Current Issues in Molecular Biology, 48(11), 1230. https://doi.org/10.3390/cimb48111230

Vancouver

Jeong U, An J, Park N, Min J, Lee J, Heo Y, et al. CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts. Current Issues in Molecular Biology. 2026;48(11):1230. doi:10.3390/cimb48111230

BibTeX
@article{Jeong2026,
  author = {Jeong, Uk and An, Ji-Hun and Park, Na-Hyun and Min, Jin-Woo and Lee, Jun-Chae and Heo, Yu-Ran and Lee, Jae-Ho},
  title = {CCND2 Expression in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: Prognostic and Transcriptomic Associations in TCGA and GEO Cohorts},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {11},
  pages = {1230},
  doi = {10.3390/cimb48111230}
}
Kostenlos starten →